ELETRIPTAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Eletriptan, and what generic alternatives are available?
Eletriptan is a drug marketed by Annora Pharma, Aurobindo Pharma, Carlsbad, Chartwell Rx, Mylan, Regcon Holdings, Stevens J, Teva Pharms Usa, and Zydus Pharms. and is included in nine NDAs.
The generic ingredient in ELETRIPTAN is eletriptan hydrobromide. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the eletriptan hydrobromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Eletriptan
A generic version of ELETRIPTAN was approved as eletriptan hydrobromide by ZYDUS PHARMS on June 16th, 2017.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ELETRIPTAN?
- What are the global sales for ELETRIPTAN?
- What is Average Wholesale Price for ELETRIPTAN?
Summary for ELETRIPTAN
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 9 |
| Drug Prices: | Drug price information for ELETRIPTAN |
| What excipients (inactive ingredients) are in ELETRIPTAN? | ELETRIPTAN excipients list |
| DailyMed Link: | ELETRIPTAN at DailyMed |
US Patents and Regulatory Information for ELETRIPTAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annora Pharma | ELETRIPTAN HYDROBROMIDE | eletriptan hydrobromide | TABLET;ORAL | 219143-001 | Jul 7, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Zydus Pharms | ELETRIPTAN HYDROBROMIDE | eletriptan hydrobromide | TABLET;ORAL | 206409-002 | Jun 16, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Chartwell Rx | ELETRIPTAN HYDROBROMIDE | eletriptan hydrobromide | TABLET;ORAL | 205186-001 | Aug 29, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
